Linden Thomas Advisory Services’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.3M Sell
27,476
-10,455
-28% -$2.77M 1.07% 7
2026
Q1
$4.16M Sell
37,931
-14,581
-28% -$2.08M 0.4% 60
2025
Q4
$8.74M Sell
52,512
-287
-0.5% -$48K 0.89% 10
2025
Q3
$10.3M Buy
52,799
+229
+0.4% +$37.7K 1.05% 9
2025
Q2
$4.75M Sell
52,570
-667
-1% -$52.7K 0.52% 36
2025
Q1
$3.18M Buy
53,237
+1,076
+2% +$99.5K 0.41% 53
2024
Q4
$6.91M Sell
52,161
-313
-0.6% -$29.4K 0.88% 7
2024
Q3
$2.75M Sell
52,474
-196
-0.4% -$9.2K 0.38% 64
2024
Q2
$3.19M Buy
+52,670
New +$3.65M 0.49% 34

Other funds holding ALAB

Linden Thomas Advisory Services's ALAB Position: Q2 2026 in Review

Linden Thomas Advisory Services reduced its Astera Labs (ALAB) stake by 28% in Q2 2026, selling an estimated $2.77M and leaving 27,476 shares worth $13.3M. The position accounts for 1.07% of the portfolio, ranked #7.

Linden Thomas Advisory Services first reported a position in ALAB in Q2 2024 and has held it in 9 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Linden Thomas Advisory Services held 27,476 shares of Astera Labs worth $13.3M as of Q2 2026.
  • Linden Thomas Advisory Services sold 10,455 Astera Labs shares in Q2 2026, an estimated $2.77M.
  • Astera Labs made up 1.07% of Linden Thomas Advisory Services's portfolio in Q2 2026, its #7 holding.
  • Linden Thomas Advisory Services first reported a position in Astera Labs in Q2 2024 and has held it in 9 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.